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1. INTRODUCTION 
1.1 Epidemiology and relevant aspects about oocyte donation pregnancies 
Since the first successful use of donated oocytes in 1984 (Lutjen P., 1984), the number of oocyte 
donation (OD) cycles in Europe and United States has dramatically increased. In 2010 in Europe the 
total number of IVF/ICSI (In Vitro Fertilization/ Intracytosplasmic Sperm Injection) cycle was 
550,296, corresponding to 1,000 cycles for one million people. The number of OD cycles was 
25,187, representing 4.5% of all the IVF/ICSI cycles (de Mouzon J., 2012). The ICMART report on 
worldwide ART (Assisted Reproductive Techniques) data in 2006 is the most comprehensive global 
statistical report to date. The paper showed that one of the most remarkable trends is the steady 
increase in the number of OD cycles from 14,887 in 2000 to 36,272 in 2006 
(http://www.icmartivf.org/toolbox/toolbox-main.html). Oocyte donation is associated with the 
highest success rate among assisted reproductive techniques. Centers for Disease Control and 
Prevention report publishing data about oocyte donation cycles in USA in 2012, reported an 
average of 56% of transfers resulted in live births, independent of recipient age, while 37% of 
transfers resulted in singleton live births showing that implantation rates are affected by oocyte age 
and not recipient age (CDC, American Society for Reproductive Medicine, Society for Assisted 
Reproductive Technology, 2012 Assisted Reproductive Technology National Summary Report). In 
these circumstances, OD nowadays has become a common treatment option, especially to overcome 
infertility due to advanced age. The increase in maternal age is a social multifactorial phenomenon 
with a general trend all over the world, and in Europe the percentage of older mothers, defined as 
women giving birth at 35 years or older, ranged from 10.9 in Romania to 34.7% in Italy, with a 
Europe median of 19.7% in 2010 (European perinatal health report, 2010).  This success has lead 
obstetricians to face more and more frequently the assistance to pregnant women who undergo 
oocyte donation with a consequence of an increasing interest in the impact of oocyte donation on 
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several aspects. On the other side, while oocyte donation is widely offered to achieve pregnancy, 
there is a paucity of information about several aspects, such as maternal and fetal outcomes, for 
counseling couples considering this option or with an ongoing pregnancy.  
In this perspective, as nowadays first trimester maternal and fetal assessment has become a pivotal 
part of antenatal care, pregnant women from donated oocytes routinely undergo first trimester 
Down syndrome screening at 11-13+6 weeks. This screening is performed by combining background 
risk of maternal age to measurement of nuchal translucency (NT) and two fetoplacental markers in 
maternal serum, free β-hCG and pregnancy-associated plasma protein-A (PAPP-A). There are many 
aspects that lead to consider the possibility that OD pregnancies can show differences compared to 
spontaneous pregnancies or IVF/ICSI autologous pregnancies. In oocyte donation pregnancies in 
fact the distinction between the donated oocyte, fully allogeneic to the recipient, and the hormonal 
prepared uterine compartment of the mother, could potentially have an impact on placentation. In 
case of Down syndrome screening, while first trimester serum markers of aneuploidies is well 
established in spontaneous pregnancy, in pregnancy after IVF/ICSI treatment has shown to be 
different, requiring specific precautions (Gjerris et al 2012). On the other side, while some studies 
showed that pregnancies achieved with in vitro fertilization (IVF) of donor oocytes are at increased 
risk of obstetrical complications, especially pre-eclampsia (PE), in comparison to spontaneous and 
IVF with homologous oocytes (Helmerhorst FM., 2004; McDonald SD., 2009; van der Hoorn MPL 
et al., 2010), less is known about physiology and physiopathology of the interaction between the 
embryo and the mother, of which placentation is one of the more evident epiphenomenon. 
1.2 Vascular regulation during placentation: highlights 
Placental extravillous trophoblast (EVT) migration to, invasion and remodeling of the uterine spiral 
arteries during the first trimester of human and nonhuman primate pregnancy are fundamentally 
important processes thought to be essential in promoting blood flow to and development of the 
  P a g .  | 4 
	  
fetus. In normal pregnancy, in fact the spiral arteries in the placental bed are invaded by trophoblast, 
which becomes incorporated into the vessel wall and replaces the endothelium, muscular layer and 
neural tissue (Brosens IA., 1972; Pijnenborg R., 2006). These physiological changes convert the 
spiral arteries from narrow muscular vessels to wide non-muscular channels independent of 
maternal vasomotor control, leading to an increase of 50-fold of the uterine blood flow (Rosenfeld 
CR, 1977). The disintegration of the wall of uterine vessels, therefore, is only insufficient to explain 
major changes in uterine resistence to blood flow (Jauniaux E., 1992). In several animal species 
(such as horses, pigs and all ruminants) the fall in uterine vascular resistance occurs without 
destruction or invasion of the maternal uterine tissue and therefore, the vascular transformation 
secondary to placentation may also result from variations in circulating steroid and protein 
hormones. At the same conclusion came Jurkovic and co-workers as they found no difference in the 
mean RI of uterine and spiral arteries between intrauterine and ectopic human pregnancies, 
suggesting that uterine vascular changes occur even if the placentation site is outside the uterine 
cavity (Jurkovic et al 1992). 
Along with the anatomic changes, the dramatic increase in uterine blood flow during pregnancy is a 
complex event. The increases in de novo uterine vascular prostacyclin (PGI2) secretion and in the 
expression of uterine artery endothelial of cytosolic phospholipase A2 (cPLA2), cyclooxygenase-
1/2 (COX-1), and either PGI2 synthase (PGIS) accompany the rise in the uterine blood flow. These 
changes are partly mediated by increase in the plasma levels and actions of estrogen via the 
classical estrogen receptors (ERs). Infusion of estradiol-17β (E2β) in sheep causes rise in uterine 
blood flow, increases the uterine artery endothelial expression of cPLA2, COX-1, and PGIS, which 
leads to increases of the stable PGI2 metabolite, 6-keto-Prostaglandin F1α (6-keto-PGF1α). In 
human umbilical vein endothelial cells (HUVECs), E2β has also been shown to selectively 
stimulate PGI2 production in vitro primarily via ER-α (Jobe SO. Et al, 2012). There is also a 
substantial body of literature showing that estrogen-induced and pregnancy-associated rises in 
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umbilical blood flow are, to a great extent, mediated by an upregulation of the endothelial 
production of the potent vasodilator NO, via increasing eNOS protein expression, and by increasing 
eNOS activity (Pastore MB. et al, 2012).  The same authors conclude that although PGI2 is a potent 
vasodilator, its role in pregnancy is not as well understood as that of NO, which has been shown to 
have a definitive role in partly regulating uteroplacental blood flow during gestation.  
In these circumstances, estrogen may be such modulator of uteroplacental vascular function. 
Several groups have documented the presence of ERs in uterine and other reproductive and non-
reproductive arteries (Chang K., 2008). The vascular actions of estrogens are mediated via the 
classical estrogen receptors (ERs), ER-α and ER-β.1 Although these two ERs exhibit substantial 
homology, they are structurally and functionally distinct. Vascular endothelial estrogenic responses 
are classified as genomic (classical/nuclear) and nongenomic (nonclassical/membrane). Estrogen 
binding to the substantially more abundant nuclear receptors regulates gene transcription, whereas 
the less abundant membrane receptors (3 to 5% of the total ERs) control very rapid activation of 
endothelial nitricoxide synthase (eNOS) and thus nitricoxide (NO)-mediated vasodilatation (Pastore 
MB. Et al,  2012). Up to 90% of estrogens synthesized in the syncytium (estradiol, estrone, and 
estriol) enter preferentially the maternal circulation. The major reason for directional movement of 
newly formed steroid into the maternal circulation is the nature of the hemochorioendothelial form 
of placentation. In this system, steroids secreted from the syncytiotrophoblast can enter maternal 
blood directly. Steroids that leave the syncytium toward the fetal compartment, however, do not 
enter fetal blood directly. First, steroids traveling toward the fetus must traverse the 
cytotrophoblasts and then enter the connective tissue of the villous core. Steroids in this space can 
reenter the syncytium. Second, steroids that escape the villous core must then traverse the wall of 
the fetal capillaries to reach fetal blood. Steroids in the fetal capillaries of the villous core then can 
reenter the connective tissue of the villous core and then the syncytium. The net result of this 
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hemochorial arrangement is that there is substantially greater entry of steroids into the maternal 
circulation compared with the amount that enters the fetal blood.  
While it has been demonstrated that estrogens has in fact an essential role in promoting placental 
villous blood vessel development through their impact on angiogenesis and expression of 
angioregulatory growth factors and successful placentation and embryonic/fetal growth are 
dependent upon optimal vascularization of the villous placenta (Albrecht ED & Pepe GJ, 2010), to 
our knowledge there are no data on estrogen maternal blood level in OD pregnancy compared to 
spontaneous or IVF pregnancy. In baboon pregnancies, it has been shown that prematurely 
elevating estrogen levels in the first trimester can suppress trophoblast remodeling of the uterine 
spiral arteries and have an impact on uterine and umbilical blood flow dynamics (Aberdeen GW et 
al., 2012). It is possible indeed that hormonal administration to prepare endometrial receptivity in 
recipients during early pregnancy can modify the normal endocrine milieu and may interfere with 
early events of placentation. 
1.3 Uteroplacental blood flow assessment by ultrasound and its clinical significance 
In a non gravid state and at the very beginning of pregnancy the flow in uterine artery is of high 
pulsatility with a high systolic flow and low diastolic flow, with the presence of a physiological 
early diastolic notch observed in the Doppler spectrum. Resistance to blood flow gradually drops 
during gestation as greater trophoblastic invasion of the myometrium takes place. During pregnancy 
there is a significant increase in uterine artery compliance between 8 and 16 weeks, which 
continued to a lesser extent until 26 weeks’ gestation. This physiologic change in compliance 
resulted in the loss of the diastolic notch, indicator of increased uterine vascular resistance,  
between 20 and 26 weeks’ gestation. A range of common complications of pregnancy, 
encompassing recurrent first and second trimester losses, fetal growth restriction (FGR), early-onset 
preeclampsia, spontaneous preterm labour and preterm premature rupture of the membranes, are 
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associated with varying degrees of failure to anatomically transform the spiral arteries of the 
placental bed (Burton GJ., 2009). While PE is not a homogeneous condition, as late-PE is thought 
to be a manifestation of an underlying metabolic disorder with increased insulin resistance, 
histological studies showed that early onset severe PE- requiring delivery before 34 weeks - is 
associated with impaired placentation because of defective or absent remodelling of the myometrial 
segment of the utero-placental arteries (Brosens et al., 1972 and 2010). Doppler studies have 
demonstrated that a high proportion of pregnancies developing early-PE have increase in the 
impedance to flow in the uterine arteries manifested as increased PI as a consequent defective or 
absent remodelling of the myometrial segment of the utero-placental arteries (Papageorghiou A., 
2001 and 2004; Plasencia W., 2007) and meta-analyses show that uterine artery Doppler analysis 
can predict women at increased risk of preeclampsia (Cnossen et al, 2008). 
This process of placentation is reflected in the measurement of impedance to flow in the uterine 
arteries which can be investigated by the measurement of uterine artery pulsatility index (PI) (Yu et 
al., 2005; Plasencia et al., 2007). The uterine artery can be evaluated by direct visualization and 
after the acquisition of the spectrum is possible to obtain the blood flow velocity at peak systole 
(maximal contraction of the heart) and peak diastole (maximal relaxation of the heart) and the 
medium value. These values are then computed to derive a ratio. The most common approach is to 
measure the PI, calculated by the following equation: PI = (peak systolic velocity - end diastolic 
velocity) / time averaged velocity = (PSV - EDV) / TAV in which the peak of systole is divided by 
the sum of systole and diastole. Two types of uterine artery Doppler waveform analysis techniques 
have emerged for prediction of preeclampsia, as well as other disorders associated with impaired 
placentation (eg, fetal growth restriction, preeclampsia): (1) presence or absence of diastolic 
notching (unilateral, bilateral) of the uterine arcuate vessels, and (2) flow waveform ratios (eg, high 
resistance or pulsatility index, systolic/diastolic ratio).  
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Few histological and immuno-histochemical studies investigate the placenta in the oocyte donation 
(OD) pregnancy and consider the hypothesis that placenta may work differently in OD pregnancy 
compared to spontaneous pregnancies or pregnancy form in vitro fertilization (IVF) and to our 
knowledge none studied no placental markers and Doppler velocimetry of uterine arteries in OD. 
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2. HYPOTHESIS AND AIMS OF THE STUDY 
To investigate the hypothesis that placentation in oocyte donation pregnancies presents differences 
in comparison to pregnancies form IVF and spontaneous, as a result of alteration in normal 
placental and fetal-maternal interaction responsible of physiological placentation, due to genetic or 
hormonal factor and abnormal uterine and placental perfusion, through the evaluation of placental 
perfusion and placental markers, we tested the following:  
1. Is there any difference in PI of uterine arteries in the three groups and in the three 
trimesters of pregnancy? 
2. Is there any difference in maternal serum levels of free β-hCG and pregnancy-
associated plasma protein-A (PAPP-A)?  
3. Is there any difference in maternal serum levels of estrogens in OD pregnancies, 
in vitro fertilization/intracytoplasmic sperm injection pregnancies with 
autologous oocytes (IVF/ICSI) and spontaneous pregnancies? 
4. Are there any anomalies of nuchal translucency? 
5. Are there potential differences in Down syndrome screening between OD 
pregnancies, in vitro fertilization/intracytoplasmic sperm injection pregnancies 
with autologous oocytes (IVF/ICSI) and spontaneous pregnancies due to any of 
the above alterations? 
 
 
 
 
  P a g .  | 10 
	  
3. METHODS 
In order to test our hypothesis we performed two studies concurrently.  
3.1 First study  
The first study was a prospective longitudinal study in singleton pregnancies to analyze uterine 
arteries Doppler in 3 steps: 11+0-13+6 weeks, 19+0-22+0 weeks, 30+0-32+0weeks. The OD study 
group included 55 OD IVF/ICSI - oocyte recipients pregnancies compared to 122 singleton 
spontaneously conceived pregnancies (Controls) and 48 pregnancies obtained with autologous 
IVF/ICSI randomly selected from our database of patients attending our antenatal clinic during the 
same study period and fulfilling the following reported criteria. All patients were attending our 
center from January 2013 to January 2015 for routine assessment of risk for chromosomal 
abnormalities by measurement of fetal nuchal translucency (NT) thickness and maternal serum free 
beta-human chorionic gonadotropin (β-hCG) and pregnancy-associated plasma protein-A (PAPP-A) 
at 11 + 0 to 13 + 6 weeks’ gestation. Written informed consent was obtained from the women 
agreeing to participate in the study, which was approved by the Institution Review Board. Recorded 
patient characteristics included maternal age, racial origin (Caucasian, Afro-Caribbean, South 
Asian, East Asian or mixed), method of conception (spontaneous or assisted, requiring the use of 
ovulation drugs), smoking status during pregnancy, personal and obstetric history, including parity 
(parous or nulliparous if no previous pregnancies at or after 24weeks). Maternal weight and height 
were also measured and the body mass index calculated in kg/m2. From this population we 
considered 55 consecutive singleton and nulliparous pregnancies obtained with donor oocyte 
(no=55). Further criteria of inclusion were 1) successful recordings of uterine Doppler velocity 
waveforms, 2) absence of pre-existing maternal diseases (diabetes, chronic hypertension, renal 
disease), 3) absence of fetal structural or chromosomal anomalies, 4) exhaustive follow-up (i.e. 
delivered in our unit allowing confirmation of the occurrence of maternal and fetal complications).  
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All ultrasound examinations were performed transabdominally using Voluson E8 and Voluson 730 
Expert ultrasound machines (GE Medical Systems, Milwaukee, WI, USA). Transabdominal 
ultrasound examination was carried out for the measurement of fetal crown–rump length (CRL) and 
NT thickness, diagnosis of any major fetal defects and measurement of uterine artery pulsatility 
index (PI). For the Doppler studies a sagittal transabdominal section of the uterus was obtained and 
the cervical canal and internal cervical os were identified. Color Doppler was used to visualize in 
turn the left and right uterine arteries on either side of the cervix before 14 weeks’ gestation.  
Subsequently, the transducer was gently tilted from side to side and color flow mapping was used to 
identify each uterine artery along the side of the cervix and uterus at the level of the internal os.  
After 14 weeks  (at 19+0 to 22+0 weeks and at 30+0 to 34+0 weeks) Color Doppler was used to 
visualize in turn the left and right uterine arteries at the apparent crossover with the external iliac 
arteries. Pulsed wave Doppler was used with the sampling gate set at 2 mm to cover the whole 
vessel and care was taken to ensure that the angle of insonation was less than 30◦. When three 
similar consecutive waveforms were obtained the PI was measured and the mean PI of the left and 
right arteries was calculated. All ultrasound and Doppler studies were carried out by 2 sonographers 
(L.M. and P.I.C.) who had received the appropriate Certificate of Competence in the 11 + 0 to 13 + 
6 weeks’ scan and Doppler of The Fetal Medicine Foundation (www.fetalmedicine.com).  
After this evaluation,  in order to test differences in maternal serum concentration of 17 β – 
estradiol between the groups, we collected 10 ml of blood from forearm vein for 82 spontaneous, 19 
homologous IVF/ICSI  and 10 OD  pregnancies, selected randomly from this cohort after the 
ultrasound examination  at 11 + 0 to 13 + 6 weeks’ gestation. Serum samples were suddenly 
processed and assayed for 17 β – estradiol using the Electro Chemo Luminescence in Immunoassay 
(ECLIA – Elecsys/Cobas®) method to calculate the pg/mL concentration. We analyzed then the 
relationship between gestational age, estrogen concentration and uterine arteries Doppler. 
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Statistical analysis was performed using the Statistical Package for Social Science version 17.0 
(SPSS Inc., Chicago, IL, USA). Usual descriptive statistics were computed considering 3 main 
groups (spontaneously conceived pregnancies (Controls), autologous IVF/ICSI pregnancies 
(Autologous IVF/ICSI), oocyte donation pregnancies (OD IVF/ICSI). The significance of the 
differences between groups’ means was tested using one-way analysis of variance (ANOVA) and 
following the Fisher’s Least Square Difference Method. Means, standard deviations, medians and 
other quartiles, when appropriate, were used for description.  The p values were reported, and a p 
less than 0.05 (two tails) was considered for the statistical significance. Finally, 95% confidence 
intervals were also computed. 
3.2 Second study  
The second study was a cohort study performed to test differences in first trimester Down 
Syndrome screening markers. We analyzed data of singleton pregnant women who underwent their 
first trimester screening for aneuploidies between January 2000 and June 2013 carried out in a 
single reference, quality controlled and accredited laboratory. We collected 13624 spontaneously 
conceived pregnancies (Controls), 171 oocyte donation pregnancies (OD IVF/ICSI), and 76 
autologous IVF/ICSI pregnancies (Autologous IVF/ICSI). In order to evaluate how older uteri 
contributed to explain the change in markers’ concentrations, we then selected a cohort of 802 
spontaneously conceived pregnancies with maternal age matched to OD recipients’ age (Age-
matched Controls). To this aim we excluded, in the spontaneous group, all patients younger than the 
youngest OD recipient. The age range was 38-46 years and the mean age 39.7 (±1.53) years. All 
participants granted a written informed consent.  
First trimester combined screening for Down syndrome was performed at 11-13+6 weeks of 
pregnancy. The screening was performed according to the recommendation of the Fetal Medicine 
Foundation for nuchal translucency measurement, and gestational age was calculated from the 
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crown-rump length (CRL) both in spontaneous and in assisted reproductive technique (ART) 
pregnancies. The measurement of the concentration of free β-hCG and PAPP-A by 
immunofluorescence was carried out in a single, quality controlled, accredited reference laboratory 
(Bi-tech Ltd, Milan, Italy) which employed the following fully automatic random access 
immunoassays analyzer systems: the COBAS 6000 e601 system of Roche Germany Holding GmbH 
and the KRYPTOR system of Brahms GmbH. As concentrations of free β-hCG and PAPP-A are 
influenced by the machine, reagents used, gestational age, maternal weight, ethnicity, gravidity and 
smoking statuses, the measured marker levels are expressed as multiples of the gestation-specific 
normal median value (multiples of the median - MoM) after adjusting for these characteristics. No 
corrections for the mode of conception were applied by the laboratory. We used the software 
program PRISCA for the routine calculation of Trisomy 21 (T 21) and Trisomy 18 (T 18) during 
the first trimester. We used the donor age to calculate the age related risk of Down syndrome. When 
risk was equal or greater than 1 in 350 for T 21 (the cut off was customized in the lab to obtain a 
5% overall screen positive rate) or 1 in 150 for T 18, the pregnant women were routinely offered 
invasive diagnosis by chorionic villus sampling or amniocentesis for fetal karyotyping. We 
compared free β-hCG and PAPP-A MoM values among Controls, Age-matched Controls, OD 
IVF/ICSI and Autologous IVF/ICSI. Furthermore, to study the effect of oocyte donation on the first 
trimester screening test, we also compared the NT values normalized to crown-rump length among 
the four groups. Information about NT measurements and patients characteristics were collected 
from patients records in the same laboratory where serum markers measurements were obtained. To 
compare serum maternal analytes concentration between the groups we excluded multiple 
gestations, structural fetal malformations and chromosomal abnormalities. In OD pregnancies, all 
women were advised to take estradiol valerate 2 mg, 3 tablets daily, and 400/600 mg of micronized 
progesterone vaginally/daily during preparation of transfer and until the end of the first trimester. 
No patients in the oocyte donation group underwent a simultaneous ovarian stimulation. All the 
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embryos transferred were fresh. Information about days of embryo culture, culture medium and 
number of embryo transferred were not available.  IVF/ICSI patients underwent hormonal 
stimulation to obtain controlled ovarian stimulation using recombinant gonadotropins preparations. 
Protocols of controlled ovarian stimulation were decided individually according to each patient’s 
clinical characteristics. 
Statistical analysis was performed using the Statistical Package for Social Science version 17.0 
(SPSS Inc., Chicago, IL, USA). Usual descriptive statistics were computed considering 4 main 
groups (spontaneously conceived pregnancies (Controls), N=13624; oocyte donation pregnancies 
(OD IVF/ICSI), N=171; autologous IVF/ICSI pregnancies (Autologous IVF/ICSI), N=76; 
spontaneously conceived age-matched pregnancies (Age-matched Controls), N=802). The 
significance of the differences between groups’ means was tested using one-way analysis of 
variance (ANOVA) and Student’s t test for post-hoc comparisons, following the Fisher’s Least 
Square Difference Method. The Kruskal-Wallis one-way non parametric ANOVA on medians was 
also applied to confirm the results, taking into account the skewedness of the distributions of the 
variables implied. Means, standard deviations, medians and other quartiles, when appropriate, were 
used for description.  The p values were reported, and a p less than 0.05 (two tails) was considered 
for the statistical significance. Finally, 95% confidence intervals were also computed. 
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4. RESULTS 
4.1 First study  
Table 1 presents the baseline characteristics of the study population. As expected, mean maternal 
age varied among groups (Controls: 32,8 ± 5,02 years; Autologous IVF/ICSI: 36,6 ± 4,24 years; 
OD IVF/ICSI - oocyte recipients: 43,2(4,74) years). All women are no smokers and primigravida. 
Mean Body Mass Index is similar among all groups: Controls 22,4 ± 3,78; Autologous IVF/ICSI 
23,0 ± 3,86; OD IVF/ICSI 22,4 ± 3,61. All IVF and OD and 99% of the totality of controls was of 
southern European Caucasian ancestry.  
When mean uterine artery PI at 11-13+6 weeks of the 3 groups of pregnancies were compared a 
difference was found between Controls and Autologous IVF/ICSI [1,679 (DS 0,456) and 1,706 (DS 
0,481)] and OD IVF/ICSI - oocyte recipients [1,415 (DS 0,486)],  showing the latter a reduced 
value [IC95% - p 0.001 (OD vs. Spontaneous conceived pregnancies) and p 0.007 (OD vs. 
Autologous IVF/ICSI)] (Table 2). By weeks, between 11 and 13+6 weeks, uterine arteries PI 
decreased with mean level of 1.68 at 11,5 weeks, 1.68 at 12,5 weeks and 1.43 at 13,5 weeks. The 
same was observed at 20 weeks: Controls 0,96 (0,294), Autologous IVF/ICSI 1,15 (0,407), OD 
IVF/ICSI - oocyte recipients 0,80 (0,292) (p < 0.05).   In the third trimester, at 30-32 weeks, only 
the analysis between OD and spontaneous conceived pregnancies showed the same trend (p 0.018) 
(Table 2).  The analysis of the variation of mean uterine PI between third and first trimester (Delta 
PI) did not reach the significance (IC95% - p 0,166 between all groups) (Figure 1).  
We performed then analysis of maternal serum level of  17 β – estradiol, expressed in pg/ml at 11-
13+6 weeks.  By groups the mean (IC 95%) and the Standard Deviation in brackets (DS) was: 
controls 2844,93 (1516,29),  autologous IVF/ICSI  2121,50 (1387,62) and OD IVF/ICSI - oocyte 
recipients 1705,33 (380,61). For Control group a more detailed analysis could have performed due 
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to numerosity of cohort. We have found then: minimum value of 568, First Quartile 1650, Second 
Quartile 2216, Third Quartile 2972,  Maximum 8365  media = 2578 s = 1408. Serum level of  17 β 
– estradiol grows between 11 and 13+6 weeks, with mean level of 2423 at 11,5 weeks, 2521 at 12,5 
weeks and 4654 at 13,5 weeks, showing that gestational age was a significant contributor to 17 β – 
estradiol serum level  in spontaneous pregnancies with a R2 0.06 (Figure 3). We then correlated 
maternal serum level  of  17 β – estradiol and mean uterine artery PI at 11-13+6 weeks, but we 
could not find a clear relation at any weeks (Figure 4).  
 
4.2 Second Study 
Table 3 presents the baseline characteristics of the study population. As expected, mean maternal 
age varied among groups (Controls: 30.4 ± 3.6 years; OD IVF/ICSI - oocyte recipients: 41.9 ± 4.2 
years; OD IVF/ICSI - oocyte donors: 25.9 ± 3.7 years; Autologous IVF/ICSI: 36.0 ± 4.8 years; 
Age-matched Controls: 39.7 ± 1.5 years). Women in the OD IVF/ICSI group were more likely to be 
primigravida than Controls. The totality of patients was of southern European Caucasian ancestry.  
Comparisons of free b-hCG and PAPP-A maternal serum levels between groups are shown in Table 
4.  Free b-hCG levels were significantly higher both in OD IVF/ICSI (1.44 ± 1.06 MoM) and 
Autologous IVF/ISCI (1.48 ± 1.02 MoM) compared to Controls (1.15 ± 0.84 MoM; p < 0.05) and 
Age matched Controls (1.18 ± 0.98 MoM; p < 0.05). Free b-hCG levels did not differ respectively 
between OD IVF/ICSI and Autologous IVF/ISCI and between Controls and Age-matched Controls. 
PAPP-A levels did not significantly differ among the four groups (Controls: 1.10 ± 0.89 MoM; 
Age-matched Controls: 1.12 ± 0.73 MoM; OD IVF/ICSI: 1.09 ± 0.80 MoM; Autologous IVF/ICSI: 
1.09 ± 0.56 MoM).  
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Table 4 presents the comparison of NT values of 13624 spontaneously conceived pregnancies 
(Controls) versus either the 802 spontaneously conceived age-matched pregnancies (Age-matched 
Controls), the 171 oocyte donation pregnancies (OD IVF/ICSI) and the 76 autologous IVF/ICSI 
pregnancies (Autologous IVF/ICSI). Overall, significantly lower NT was detected in Controls (1.41 
± 0.36 mm) compared to Age-matched Controls (1.44 ± 0.42 mm; p < 0.05), OD IVF/ICSI (1.46 ± 
0.44 mm; p < 0.05) and Autologous IVF/ICSI (1.51 ± 0.34 mm; p < 0.05). NT values were not 
significantly different between Age matched Controls, OD IVF/ICSI and Autologous IVF/ICSI. 
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5. DISCUSSION 
5.1 Main findings  
We found that oocyte donation has a significant impact on placentation and blood placental 
markers' concentrations in the first trimester of pregnancy. We observed a statistically significant 
lower uterine arteries doppler pulsatility index in OD pregnancies in the first, second and trimester, 
in the latter case exclusively between OD and spontaneous conceived pregnancies. The analysis of 
the variation of mean uterine PI between third and first trimester did not reach the significance. 
Furthermore we found a higher value of free bhCG MoM in OD IVF/ICSI pregnancies and 
autologous IVF/ICSI compared to spontaneous pregnancies. Although we are not in the position to 
verify or falsify biological reasons of the alteration, our data allows us to hypothesize that it might 
be due to the IVF technique. In fact the observed alterations in OD IVF/ICSI pregnancies are 
similar to autologous IVF/ICSI pregnancies. A marginal decrease in NT was observed in Controls. 
However, this very small difference, even if interesting to be investigated (due to different 
accumulation of fluid in the third space?) is not clinically relevant and it is likely due to the higher 
numbers of this group, as well as to operator effect, with ART pregnancies more likely to be 
scanned by a small subset of operators linked to ART clinics. We did not find any difference in 
maternal serum concentration of 17-β estradiol at 11-13+6 weeks between groups, neither a relation 
between uterine arteries Doppler and 17-β estradiol in spontaneous pregnancies. 
5.2. Discussion of the main findings with other reported data 
Only one paper have been published on uterine arteries Doppler evaluation in oocyte donation 
pregnancies (Rizzo G., 2015). Rizzo and co-workers studied uterine artery and did not find any 
differences in oocyte donation pregnancies compared to IVF or spontaneous conceived pregnancies. 
Since mean uterine artery PI and placental volume values change with gestational age, they 
converted PI value into a multiple of the expected median (MoM), calculated from Fetal Medicine 
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Foundation reference limits for singleton pregnancies, after correction for gestational age, body 
mass index and maternal ethnicity. It is possible that this represents a bias as converting the PI 
values in MoM, as MoM is made by the ratio of the expected median, but is not known which is the 
correct median value for oocyte donation as no reference curves have been built, but the use of the 
expected median of spontaneous pregnancy introduces a potential error.  
Few data have been published on biochemical markers in oocyte donation pregnancies and we 
found no report contrasting our results. Our data are in agreement with Bellver et al. that showed a 
slight increase of free b-hCG in OD compared to those found in naturally conceived pregnancies 
(1.20 MoM vs1.02 MoM) (p < 0.02) and no difference in PAPP-A in OD compared to 200 
singleton pregnancies achieved naturally . 
To our knowledge the only paper that studied the effect of hormonal variables on Doppler parameters is the 
one by Jauniaux and co-workers, where the authors found a correlation between 17 β – estradiol and uterine 
RI (p < 0.001) (Jauniaux E., 1992). The study was performed on 44 women between 5 and 16 weeks of 
gestation, a wide range and a small sample size.  
5.3. Limitations of the studies 
A limit of our study is the lack of information on the specific medical causes driving infertile 
women to opt for oocyte donation. Oocyte donation pregnancies form indeed a heterogeneous group 
that includes either old women or women with infertility caused or complicated by different clinical 
aspects such as premature ovarian failure, idiopathic infertility, endometriosis, and more. Each of 
these aspects taken alone may have a different impact on markers. On the other side, to collect a 
significant sample of OD pregnancies is a big effort, due to the fact that they are not referred to 
unique or specific units, such as for complicated pregnancy, and women tend to maintain privacy on 
data about OD pregnancies.  
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A limit of the uterine arteries analysis can be the relative small sample size, for sure affecting the 
hypothetic difference in maternal serum estrogen concentration. Another limit was the impossibility 
to evaluate for maternal serum concentration of progesterone. 
About Down syndrome screening markers, even if we do not know how many embryos were 
transferred, Spencer K. et al. demonstrated that vanishing twins have no impact on levels of the free 
b-hCG marker, as this marker is very rapidly cleared from maternal blood, but rather determine a 
large and significant increase in PAPP-A concentration, partially related to the time between fetal 
demise and blood sampling (Spencer K., 2010). 
5.4 Interpretation of findings and speculations on the possible impacts on clinical use 
It would be particularly interesting to understand the physio-pathological mechanism that allows 
these changes in OD pregnancies. We suggest a series of hypotheses. The observed biophysical and 
biochemical differences could reflect alterations in the first stages of placentation. (Gagnon A., 2008; 
Cetin I., 2011; Nicolaides K.H., 2011). Van der Hoorn et al. showed that OD pregnancies are 
associated with a higher incidence of pregnancy-induced hypertension and placental pathology 
(Van der Hoorn, 2010). Along with these observations, abnormal marker levels might be predictors 
of these complications in OD pregnancies. We do not have, to date, complete analysis of data about 
this issue, as we are still examining OD outcomes, but Amor et al. showed that, even analyzing data 
according to the presence or absence of pregnancy complications, biochemical marker levels are 
still altered in ART pregnancies without complications (Amor D.J., 2012).  
In addition, we know that in OD pregnancies there is a unique aspect represented by the interaction 
between the uterus and the immunogenetically unrelated embryo. Significant histological and 
immunohistochemical differences have been reported at the maternal-fetal interface of OD 
placentas (Gundogan F., 2010). Gundogan et al. demonstrated that there is a diffuse severe chronic 
deciduitis (CD) with dense fibrinoid deposition in the basal plate of OD placentas (45 % of cases), 
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where extravillous cytotrophoblast of fetal origin interfaces with and invades the maternal decidua. 
In contrast, in the non-donor IVF group the CD was observed in 8% of cases and was focal and 
mild. This study demonstrated significantly increased numbers of CD4+ T helper cells and CD56+ 
NK cells in the basal plates of oocyte donor cases. They found also in the 90% of cases in donor 
placenta the present of syncytial knots that represent the final stage of the apoptosis cascade in the 
syncytiotrophoblast. Considering the increased incidence of gestational hypertension in the egg 
donor-IVF group, the observation of increased syncytial knots was not unexpected. Although the 
authors concluded that their findings could represent a host versus graft rejection phenomenon, it 
could also represent an effort to suppress rejection. Today it is not well known the mechanism of 
maternal immune response and its characterization could supply additional insights into 
reproductive immunology and possibly the egg donor selection process. Perni et al. reported that 
placentas from donor cycles were significantly more likely to demonstrate certain pathologic 
findings: chronic villitis (P<0.001), chronic deciduitis (P=0.034), increased perivillous fibrin 
(P=0.001), ischemic change/infarction (P=0.001), and intervillous thrombi (P=0.008) (Perni SC., 
2005). There was no statistical significance with respect to decidual vasculopathy, increased 
syncytial knots, or retroplacental hematomas. Schonkeren and co-workers found in 10 out of 26 
placentas (38.5%) a lesion in several locations in the chorionic plate, consisted of a diffuse 
inflammatory infiltrate involving the entire chorionic plate from the amniotic epithelium towards 
the intervillous space (Schonkeren D., 2012). They found an associated myxomatous change in the 
mesoderm of the plate and inflammatory cells within the plate and the subchorionic space. It was 
restricted to the chorionic plate and not on the chorion laeve. In the fetal membranes there were no 
signs of the lesion. A significant relationship was found between the presence of the lesion in the 
chorionic plate and intervillositis (P=0.018), chronic deciduitis (P=0.003), presence of plasma cells 
in the decidua (P=0.002) and fibrin deposition in the decidua (P=0.007). He observed a significantly 
lower incidence of preeclampsia in the group with the lesion: 0% versus 45.5%. Preeclampsia only 
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occurred in the group without immunological lesion in the chorionic plate, regardless of the 
maternal age. This is very interesting because it is possible that immunological activation might be 
a crucial factor in protection against preeclampsia.  
In OD pregnancies the fetus is allogeneic to the gestational carrier. This creates an interesting 
immunological paradox. The mother accepts the fetus although being immunogenetically 
completely unrelated to the mother. In solid organ transplantation the same immunogenic 
dissimilarity is present; however there are some differences in medical consequences between solid 
organ transplantation and OD. In the organ transplantation the clinicians have to do a medical 
screening for the donor in order to match donor-recipient, have to use immunosuppressive drugs to 
maintain the graft, have to do a close medical follow up. Fetus specific immunological tolerance 
during pregnancy depends on a very complex network of cytokines, complement, hormones, 
immune and non-immune cells. Acceptance is not simply based on the consequence of a balance 
between the type 1 (associated with abortion) and type 2 (associated with successful pregnancy) 
cytokines, since many cytokines are pluripotent. However, in an uncomplicated pregnancy the child 
is able to survive in the semiallogeneic environment and the mother accepts the semi-allograft. In 
OD pregnancy, the mother is exposed to foreign cells and antigens, a situation that has some 
resemblance to blood transfusions and organ transplantation. It is to be conceived that the down 
regulation of the maternal alloimmune response to the fetus during OD pregnancies needs more 
adaptation compared to a spontaneously conceived pregnancy. The degree of antigenic dissimilarity 
(reflected by the number of HLA mismatches) is in general higher in OD pregnancies compared to 
spontaneously conceived pregnancies. In the transplantation setting the degree of HLA 
compatibility between the donor and recipient is relevant for graft survival. More mismatches will 
lead to poorer graft survival (Opelz G., 2007). Compared with spontaneously conceived 
pregnancies, there is a higher degree of antigenic dissimilarity in OD cases. If the five most 
immunogenic HLA antigens (HLA-A, -B, -C, -DR and -DQ) are taken into consideration, the 
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maximal number of mismatches in spontaneous conceived pregnancies would be 5. In OD 
pregnancies this could reach a maximum of 10 mismatches. Since OD pregnancies are characterized 
by more HLA mismatches, it is to be expected that a possible relationship between aspects of 
immune regulation and the number of HLA mismatches will become more apparent in OD 
pregnancies. There are different defense mechanisms adopted by the fetus. Fetal trophoblast cells 
are the crucial cell population in the placenta, which protects the fetus from destruction by the 
maternal immune system. Villous cytotrophoblast is the inner layer of the villous surface 
epithelium. Villous syncytiotrophoblast is the superficial layer facing the intervillous space. Villous 
trophoblasts lack HLA expression and do not provoke an allogeneic immune response by 
circulating maternal T cells. The remaining trophoblasts cells, the extravillous trophoblasts, are the 
dominant cell type needed for the development of all non-villous parts of the placenta. Extravillous 
trophoblast does not express HLA-A or -B, but does express HLA-E, -F, -G and -C (Hunt and Orr, 
1992), which serve as ligands for leukocyte inhibitory receptors. The consequences of these 
interactions include activation of pathways in natural killer (NK) cells and macrophages that 
interfere with the killer functions of these cells (Hunt and Orr, 1992; Hunt JS., 2006; Le Bouteiller 
P., 1997). HLA-G has potent immunomodulatory functions (McIntire and Hunt, 2005) whereas 
HLA-C and –E have shown to elicit an allogeneic immunomodulatory response by maternal NK 
and T cells (Moffett-King, 2002). Th2 cytokines, produced at the maternal–fetal interface, can 
inhibit Th1 responses, improving fetal survival but impairing responses against some pathogens 
(Wegmann TG., 1993). The human placenta produces immunosuppressive molecules as 
progesterone, prostaglandin E2, and anti-inflammatory cytokines as IL-10 and IL-4  (Hunt, 2006; 
Denison FC., 1998). If we consider the maternal side we know that during early pregnancy the 
uterus seems to be immune compromised, as T and B cells are hardly present. Macrophages and NK 
cells interact with the trophoblast cells. Decidual NK cells are different compared to peripheral NK 
cells. Decidual NK cells may recognize fetus HLA-C1 and HLA-C2 by the expression of KIR. 
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Macrophages are antigen-presenting cells and are the second most numerous types of leukocytes in 
the human decidua (Vince et al., 1994).  
The number of decidual T cells increases during pregnancy, starting with 5–20% of all CD45+ 
decidual lymphocytes in early pregnancy, till 40–80% at term (Tilburgs et al., 2010). T cells are in 
close contact with fetal trophoblast cells in the decidua; however they do not attack the non villous 
trophoblast cells, since trophoblast lack HLA class Ia expression. Fetus specific regulatory 
CD4+CD25bright T cells are present in human decidua in higher numbers compared to peripheral 
maternal blood (Tilburgs et al., 2006) suggesting an important role for these cells at the fetal– 
maternal interface. T cells are able to produce a variety of type 1 and type 2 cytokines and thereby 
may contribute to the local regulation of the fetus-specific responses within the decidua.  
Chernyshov et al. show increased percentages of intracellular IFN-c and IL-4 positive CD4+ T 
lymphocytes in group of pregnant women after oocyte donation compared with pregnant women 
after normal conception and pregnant women after IVF, confirming that allogenicity of the fetus 
induces a different activation of some intracellular cytokines (Chernyshov et al., 2008). 
Inflammatory response can limit the damage at the maternal–fetal interface and TNF-a induces the 
production of IL-10 that suppresses inflammation response. It would be interesting to verify the 
relation between serum markers' concentration and histological and immunohistochemical findings. 
To our knowledge, no studies have been performed so far to explore this relationship.  
About Down syndrome markers, as the same differences are observed either in autologous 
IVF/ICSI and OD IVF/ICSI group, the most suitable hypothesis to explain our results points to the 
fertilization technique itself and/or to the hormonal treatment used. The protocol to obtain a 
superovulation, or to establish endometrial receptivity and to support pregnancy during the first 
trimester, provides the use of high doses of gonadotropin and/or estrogen and progestin 
combinations. To our knowledge there are no data on human estrogen maternal blood levels in 
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autologous IVF/ICSI and OD IVF/ICSI, compared to data on spontaneously conceived pregnancies. 
We do however know that, in baboon pregnancy, it has been demonstrated that prematurely 
elevating estrogen levels in the first trimester can suppress trophoblastic remodeling of the uterine 
spiral arteries and have an impact on uterine and umbilical blood flow dynamics (Aberdeen G.W., 
2012). Estrogens have an essential role in promoting placental villous blood vessel development 
through their impact on angiogenesis and expression of angioregulatory growth factors. Successful 
placentation and embryonic/fetal growth are dependent upon optimal vascularization of the villous 
placenta (Albrecht E.D., 2010). It is plausible indeed that hormonal administration during early 
pregnancy can modify the normal endocrine milieu and may interfere with early events of 
placentation. Bonagura and co-workers showed that estrogen normally controls the extent to which 
the uterine arteries are transformed by placental  extravillous trophoblast EVT in primate pregnancy 
by regulating expression of VEGF and particular integrin extracellular remodeling molecules that 
mediate this process (Bonagura TW., 2012). In particular the authors found that extravillous 
placental expressions of VEGF and the α1β1 and α5β1 integrins were decreased in baboons in 
which EVT invasion and remodeling of the uterine spiral arteries were suppressed by prematurely 
elevating estradiol levels in the first trimester of pregnancy. The low levels of estradiol typical of 
early human and nonhuman pregnancy permit aggressive EVT migration and remodeling of the 
uterine spiral arteries, whereas the elevation in endogenous estradiol with advancing normal 
pregnancy is a physiologically important event which represses and thus controls the extent of 
uterine vessel transformation During the first postconception weeks, maintenance of human 
pregnancy is completely dependent on hormonal support by progestational compounds, as rising 
levels of human chorionic gonadotropin maintain production of estradiol in the maternal corpus 
luteum due to interaction between the luteinized theca and granulosa cells. The functional activity 
of maternal ovaries decreases significantly by the seventh week of pregnancy as after the seventh 
week of pregnancy the luteoplacental shift is well advanced (Prietl G., 1992). At this time there is a 
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luteal-placental transition such that more than 50% of estrogen entering the maternal circulation is 
produced in the placenta. In oocyte donation pregnancies, to create the endometrial receptivity and 
then maintain pregnancy in women without functional ovaries, and hence a corpus luteum, 
exogenous hormones need to be administered. Standard therapy is composed by oral administration 
of progesterone and estradiol valerate. Estradiol valerate is an esterified form of natural 17β-
estradiol (estradiol), the most potent endogenous human ovarian estrogen. After oral administration, 
estradiol valerate is rapidly hydrolyzed to estradiol in the intestinal mucosa. After this passage, 
estradiol, like endogenous estrogens, is metabolized in the liver and the predominant metabolites in 
postmenopausal women are estrone, estrone sulphate and estradiol sulphate. Circulating estrogens, 
including exogenous estradiol, are reversibly converted to estrone and exist in a dynamic 
equilibrium; estrone and estradiol are converted to estriol, the main urinary metabolite. Estrogens 
undergo enterohepatic recirculation via sulphate and glucuronide conjugation; the sulphates are 
mainly hydrolysed and reabsorbed, whereas the glucuronides are excreted in the bile or urine within 
48 hours of administration. Estrogens, including orally administered estradiol, passively diffuse 
through cellular membranes and bind to estrogen receptors present in the nucleus. Estradiol is the 
predominant source of estrogen in premenopausal women; after menopause, estrone is the main 
source of estrogen and is derived from peripheral conversion of androstenedione. In premenopausal 
women, serum levels of estradiol range from 0.18 to 1.1 nmol/L during different stages of the 
menstrual cycle, whereas serum estradiol levels drop to approximately 0.05 nmol/L in 
postmenopausal women (Wellington K, Perry CM, 2002). Usually oral therapy is maintained at the 
same dosage soon after the embryo transfer until the end of third trimester. Due to 
pharmocodynamic an pharmacokinetic profile, the steady state is rapidly obtained (Wellington K, 
Perry CM, 2002).  In this regimen maternal serum concentration are more or less the same during 
the entire first trimester of pregnancy. Our finding that at 11-13+6 weeks of pregnancy the maternal 
serum concentration of 17-β estradiol is not different between groups means that in oocyte donation 
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recipients at the beginning of pregnancy, when the concentration of estradiol in spontaneous 
pregnancy is demonstrated to be significantly lower (Devroey P., 1990), the maternal serum 
concentration of estrogen should be higher. It would be necessary to design larger prospective 
studies to understand the real curve of maternal hormonal concentration in order to prescribe a 
replacement therapy for recipients of donated oocytes more similar to the normal biology of first 
trimester. 
Two other aspects of our study can have an important clinical impact. Firstly, irrespectively of the 
identification of the underlying mechanism, the importance of first and second trimester evaluation 
of uterine arteries Doppler is the possibility to include this parameter into an algorithm that allow to 
individuate women at high risk for developing preeclampsia, since this condition is associated with 
an increased risk of perinatal mortality and morbidity and both short- and long- term maternal 
complications that deserve targeted antenatal care and surveillance. In this perspective it would be 
interesting to reference range specific for oocyte donation pregnancies. Secondly the markers' 
modification of our sample resemble the direction or pattern of fetuses affected by Down syndrome, 
and this can lead to a higher false positive rate in first-trimester Down syndrome screening in 
oocyte donation pregnancies. In our study we could not evaluate the statistical performance of the 
screening, as we did not observe affected fetuses in our cohort. Results obtained are probably due to 
the younger age of the oocyte donors and to the influence of “oocyte age” in the algorithm for risk, 
calculation.  
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6. TABLES AND FIGURES 
 
 
Table 1. Characteristics of the study population 
 
IVF, in vitro fertilization; ICSI, intracytoplasmic sperm injection, OD Oocyte Donation pregnancies  
(* Oocyte recipients ) 
 
 
 
 
 
  Spontaneous   Autologous IVF/ICSI   OD 
IVF/ICSI* 
 
 Min Media (DS) Max Min Media (DS) Max Min Media (DS) Max 
Age 17 32,8(5,02)   44 27 36,6(4,24)  44 33 43,2(4,74) 52 
Height 150 163,1(6,36)  180 150 164,0(5,65) 175 155 165,7(6,66)   184 
Weight 40 59,6(10,88)  98 46 61,8(10,36)   89 46 61,1 (9,28) 98 
BMI 16,8 22,4(3,78)  35,5 17,8 23,0(3,86)  34,8 17,6 22,4(3,61) 39,9 
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Table 2. Uterine Arteries Doppler Pulsatility Index (PI) 
 
 Controls Autologous    IVF/ICSI OD IVF/ICSI*  
 Media (DS) Media (DS) Media (DS) P 
Uta PI 11-13+6 w 1,679 (0,456) 1,706 (0,481) 1,415 (0,486) p < 0.05 a,b 
Uta PI 20-22 w 0,96 (0,294) 1,15 (0,407) 0,80 (0,292) p < 0.05  c,d 
Uta PI 30-32 w 0,64 (0,308) 0,52 (0,166) 0,53 (0,195) p < 0.05 e 
IVF, in vitro fertilization; ICSI, intracytoplasmic sperm injection; OD IVF/ICSI, Oocyte Donation (*Oocyte 
recipients) 
a  when comparing OD and Controls    
b  when comparing OD and Autologous IVF/ICSI      
c  when comparing OD and Controls    
d  when comparing OD and Autologous IVF/ICSI       
e  when comparing OD and Controls     
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Table 3. Characteristics of the study population 
 Controls 
(N= 13624) 
Age-matched 
Controls 
(N= 802) 
OD IVF/ICSI 
(N= 171) 
Autologous 
IVF/ICSI 
(N= 76) 
Maternal Age (years) 30.4 (3.6) 39.7 (1.5) c,d,e 41.9 (4.2)*a 
25.9 (3.7)**  
36.0 (4.8) b,f 
Weight (kg) 62.2 (11,3) 62.5 (10.4) d 60.6 (8.7) 60.0 (8.9) 
Primigravida (%) 48.5 24.4 c,d 73.6 a - 
Risk > 1/350 n/N  (%) 376 (2.8) 159 (19.8) c,d,e 10 (4.9) a 8 (10.7) b 
 
IVF, in vitro fertilization; ICSI, intracytoplasmic sperm injection 
Results are expressed as mean (SD), %, n/N (%). 
* Oocyte recipients; **Oocyte donors. 
a p < 0.05 when comparing Controls and OD IVF/ICSI 
b p < 0.05 when comparing Controls and Autologous IVF/ICSI  
c p < 0.05 when comparing Controls and Age-matched Controls 
d p < 0.05 when comparing OD IVF/ICSI and Age-matched Controls 
e p < 0.05 when comparing Autologous IVF/ICSI and Age-matched Controls 
f p < 0.05 when comparing OD IVF/ICSI and Autologous IVF/ICSI 
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Table 4. Comparison of NT, free β-hCG and PAPP-A median MoM levels in Controls versus 
Age-matched Controls, OD IVF/ICSI and Autologous IVF/ICSI  
 
 Controls 
 
(N= 13624) 
Age-matched 
Controls 
(N= 802) 
OD IVF/ICSI 
 
(N= 171) 
Autologous 
IVF/ICSI 
(N= 76) 
NT (mm) 1.41 (0.36) 1.44 (0.42) c 1.46 (0.44) a 1.51 (0.34) b 
CRL (mm) 60.6 (8.42) 61.1 (8.45) 62.2 (7.59) a 62.4 (6.83) 
Free β-hCG MoM 
Mean (SD) 
1.15 (0.84) 1.18 (0.98) d, e 1.44 (1.06) a 1.48 (1.02) b 
PAPP-A MoM 
Mean (SD) 
1.10 (0.89) 1.12 (0.73) 1.09 (0.80) 1.09 (0.56) 
 
NT, nuchal translucency; IVF, in vitro fertilization; ICSI, intracytoplasmic sperm injection; PAPP-A, 
pregnancy-associated plasma protein-A; Free β-hCG, free beta-human chorionic gonadotropin; MoM, 
multiples of the median. 
 
a p < 0.05 when comparing Controls and OD IVF/ICSI 
b p < 0.05 when comparing Controls and Autologous IVF/ICSI  
c p < 0.05 when comparing Controls and Age-matched Controls 
d p < 0.05 when comparing OD IVF/ICSI and Age-matched Controls 
e p < 0.05 when comparing Autologous IVF/ICSI and Age-matched Controls 
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Figure 1. Mean uterine arteries PI and its Δ between third and first trimester 
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Figure 2. Mean uterine arteries PI at 11-13+6 and maternal serum estrogen by groups 
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Figure 3. First trimester mean uterine arteries PI and maternal serum estrogen in 
spontaneous pregnancies by weeks 
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Figure 4. Free β-hCG MoM in spontaneous pregnancies versus oocyte donation pregnancies, 
IVF pregnancies and spontaneous age-comparable pregnancies  
	  
	  
	  
	  
Group A: Spontaneous Pregnancies 
Group B: Oocyte Donation Pregnancies 
Group C: IVF/ICSI Pregnancies 
Group D: Spontaneous age-comparable Pregnancies  
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Figure 5. PAPP-A MoM in spontaneous pregnancies versus oocyte donation pregnancies, IVF 
pregnancies and spontaneous age-comparable pregnancies 
	  
	  
	  
 
Group A: Spontaneous Pregnancies 
Group B: Oocyte Donation Pregnancies 
Group C: IVF/ICSI Pregnancies 
Group D: Spontaneous age-comparable Pregnancies 
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